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The circadian clock is an endogenous time-keeping system that is ubiquitous in animals and plants as 
well as some bacteria.  In mammals, the clock regulates the sleep-wake cycle via two basic helix-loop-
helix PER-ARNT-SIM (bHLH-PAS) domain proteins - CLOCK and BMAL1. There is emerging 
evidence to suggest that heme affects circadian control, through binding of heme to various circadian 
proteins, but the mechanisms of regulation are largely unknown. In this work we examine the interaction 
of heme with human CLOCK (hCLOCK). We present a crystal structure for the PAS-A domain of 
hCLOCK, and we examine heme binding to the PAS-A and PAS-B domains. UV-visible and EPR 
spectroscopies are consistent with a bis-histidine ligated heme species in solution in the oxidised (ferric) 
PAS-A protein, and by mutagenesis we identify His144 as a ligand to the heme. There is evidence for 
flexibility in the heme pocket, which may give rise to an additional Cys axial ligand at 20K (His/Cys 
coordination). Using DNA binding assays, we demonstrate that heme disrupts binding of CLOCK to its 
E-box DNA target. Evidence is presented for a conformationally mobile protein framework, which is 
linked to changes in heme ligation and which has the capacity to affect binding to the E-box. Within the 
hCLOCK structural framework, this would provide a mechanism for heme-dependent transcriptional 
regulation.  
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SIGNIFICANCE STATEMENT  
 
Heme proteins have several well-established functions in biology, from oxygen transport to electron 
transfer and catalysis. But in addition, there is new evidence that heme has a wider regulatory role in the 
cell. This includes a role for heme in the regulation of circadian rhythm. In this work, 
we have examined the binding of heme to human CLOCK, one of the positive elements in the circadian 
autoregulatory feedback loop. We find evidence for a conformational mobility within the heme pocket, 
and that heme disrupts binding of CLOCK to its E-box DNA. These results provide a direct link between 
heme binding and DNA partner recognition that may form the basis for a mechanism of regulatory 
control. 




The circadian clock is the internal timekeeping system that generates a daily rhythm in physiology, 
biochemistry and behaviour of almost all higher organisms and some prokaryotes. In mammalian 
systems, as in insects, a transcriptional-translational feedback loop appears to be at the core of the 
oscillator (1), and this is coupled to an evolutionarily more primitive metabolic oscillator (2). The 
transcriptional-translational feedback loop has a number of positive and negative components that drive 
interconnected loops that generate the molecular clockworks. In mammals, NPAS2 (in the forebrain) 
and CLOCK (in the suprachiasmatic nucleus) form heterodimers with BMAL1 (brain and muscle arnt-
like 1) and represent the positive limb of the feedback loop (Fig. 1). Both dimers bind to the same E-
box DNA sequence (CANNTG) to activate expression of the negative autoregulators, the three Period 
(Per) and two Cryptochrome (Cry) genes (1). PER and CRY, after various posttranslational 
modifications that build delays into the loop, then interact with the BMAL1 complexes to negatively 
regulate their own genes, thereby closing the loop (Fig. 1 and (1)). REV-ERBα, a member of the nuclear 
receptor family, also functions in the cell to repress transcription of BMAL1. 
 
There is an accumulating body of evidence that indicates that heme is a regulator of the circadian 
oscillator (3), but the mechanisms of regulation are entirely unknown. Conceptually, heme binding 
provides a simple mechanism for signal transduction because regulation by heme can be coupled to its 
ability to bind other ligands - such as oxygen (O2), carbon monoxide (CO) and nitric oxide (NO) - which 
are themselves established as important signalling molecules in cellular control (4). 
 
The two E-box binding proteins - NPAS2 and CLOCK - belong to the family of transcriptional 
regulators that contain both basic helix-loop-helix (bHLH) domains at the N-terminus as well as two 
PAS domains. High sequence identity between these two proteins (5, 6) was noted before a direct link 
between heme and any circadian protein had been established. In this work we present an analysis of 
heme binding to the PAS-A domain of human CLOCK, we examine the effect of heme on the CLOCK-
DNA binding interaction, and we present a structure for the PAS-A domain. We use this information to 
put forward ideas on how heme binding might be linked to regulation of circadian control.  
 
RESULTS 
Crystal structure of hCLOCK PAS-A. A recombinant version (N-terminal His-tagged) of the PAS-A 
domain of hCLOCK (hCLOCK PAS-A, Fig. 2) was expressed in E. coli. The purified protein 
crystallised as a homodimer in the apo-form (i.e. without heme), consistent with behavior of the protein 
during size exclusion chromatography (Fig. S2).  
 
The structure of the hCLOCK PAS-A structure is presented in Fig. 3A. The tertiary structure of the 
overall PAS fold consists of a series of antiparallel b-sheets forming a hydrophobic core in which a 
signalling molecule can bind (7). A number of a-helices are in close proximity which are believed to be 
responsible for the propagation of structural changes to the rest of the protein or to a partner protein 
when in a complex. 
 
The hCLOCK structure has close similarity to that of the O2 sensor from Rhizobium (FixL, (8)) and the 
heme-regulated phosphodiesterase from Escherichia coli (EcDOS, (9, 10), as shown in Figs. 3B,C. A 
comparison of the heme binding locations in the two structures is informative, Fig. S3. In the structure 
of hCLOCK PAS-A, histidine 144, which is implicated in heme binding as below, is found on a loop 
between two short helices and is oriented towards the β-sheets of the domain in a hydrophobic pocket. 
This hydrophobic core is a feasible heme binding pocket, as shown in Fig. S3. From the hCLOCK 
structure, it appears that H144 is a realistic proximal residue for heme and is ideally situated at the mouth 
of this hydrophobic pocket and is surrounded by numerous hydrophobic residues (Phe 121, Leu 145, 
Leu 149, Phe 157 and Leu 198) which leave adequate space for a heme molecule. A comparison with 
FixL shows that the heme in the crystal structure of FixL is located in a different location, at the opposite 
end of this hydrophobic pocket, Fig. S3A.  
 
Heme binding to hCLOCK PAS-A. Although heme is not present in the structure of hCLOCK above, 
binding of heme to the PAS-A domain of hCLOCK is clearly evident from UV-visible spectra. The 
spectrum of the oxidised, ferric derivative of hCLOCK PAS-A (lmax = 413, 533 nm, Fig. 4A) is 
consistent with heme binding to the protein and with a 6-coordinate, low spin heme species. EPR spectra 
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are in agreement with this assignment. The spectrum of heme-bound hCLOCK at 20 K (Fig. 4B) reveal 
turning points at g1 = 2.93, g2 = 2.28, and g3 ³ 1.7 typical of a low-spin, ferric (S = 1/2) heme species 
(11). These low-spin g-values are consistent with a bis-histidine heme coordination. Weak resonances 
were also observed at 4 K at geff ≈ 6.0 and geff ≈ 2, which are characteristic of high-spin ferric (S = 5/2) 
heme (Fig. S4A). In addition, a shoulder is observed on the central line and attributed to overlap of a 
second (minor) low-spin heme species (g3 = 2.45, g2 = 2.28, and g3 = 1.92). These g-values are similar 
to those previously observed for the isolated PAS-A domain of mouse Per2 (12). Empirical g-values for 
heme-bound species are well studied (11). In this case the g-values for the second species in the EPR 
are unlike those reported for either His/His or His/Met ligation, and on this basis are assigned as arising 
from a Cys/His or Cys/OH- coordination.  
 
Heme binds to apo-hCLOCK with a 1:1 stoichiometry (KD = 4.2 ± 0.25 µM, Fig. 4A inset). Heme 
dissociation from hCLOCK PAS-A was measured at 412 nm in the presence of the H64Y/V68F mutant 
of sperm whale myoglobin which has a high affinity for heme (13) (Fig. 4C). A biphasic exponential 
change was observed giving rate constants of 8.9 × 10-3 s-1 and 4.5 × 10-4 s-1 for the fast and slow phases 
respectively. This biphasic behaviour is consistent with the concept of conformational mobility within 
the heme binding site. The rate constants for heme dissociation are consistent with those derived for 
other heme regulatory such as SOUL and p22HBP (kdiss » 10-3 s-1 (14)). 
 
As for the ferric protein above, the ferrous derivative of hCLOCK PAS-A (lmax = 425, 533 and 558 nm, 
Fig. 4D), shows characteristic heme peaks, which is again consistent with 6-coordinate, low spin heme. 
On the basis of similarities to ferrous NPAS2 (lmax = 423, 530 and 558 nm (15)), which is assigned as 
a His/His ligated heme species (16), we assign hCLOCK PAS-A as the same. Ferrous hCLOCK binds 
both CO (lmax = 421, 540 and 570 nm, Fig. 4D) and NO (lmax = 421, 531 and 556 nm, Fig. 4D), with a 
presumed His/CO ligation. In kinetic experiments measuring CO binding to hCLOCK PAS-A, pseudo-
first order rate constants (kobs) showed a non-linear dependence on the concentration of CO, but were 
linearly dependent on the protein concentration, Fig. 4E. This kinetic behaviour is consistent with a 
dynamic equilibrium of the protein structure (P) prior to CO binding (17), presumably leading to loss of 
one of the axial His ligands, eq [1], 
 P		#$%&⎯(		#	%	)⎯⎯*		P∗		$,-,			#$/&⎯⎯⎯⎯⎯⎯⎯(			0,-,		#/)⎯⎯⎯⎯⎯⎯⎯* 		P − CO									(Eq	1) 
 
and in the case where CO binding is irreversible (k-2<< k1k2/k-1) a hyperbolic dependence of kobs on CO 
concentration is observed, eq. [2].  
 
kobs = k1k2[CO]/(k-1 + k2[CO]) (Eq 2) 
 
The addition of oxygen to ferrous protein under anaerobic conditions gave no evidence of a ferrous-oxy 
intermediate – this might be linked to the low reduction potential of the heme in hCLOCK PAS-A, 
which has been previously determined (18, 19) as -111 mV vs NHE.  
 
Based on a sequence alignment with NPAS2, Fig. S5, we identified His144 as a possible ligand to the 
heme in hCLOCK (equivalent to the axial His119 ligand in NPAS2). The corresponding spectra of the 
ferric H144A mutant of hCLOCK PAS-A in the presence of heme showed a broad, strongly blue-shifted 
Soret band (lmax = 374 nm) which is different from that of the ferric wild-type protein and which is not 
consistent with a bona fide heme protein, Fig. 4F. On this basis, we assign His144 as one of heme ligands 
in hCLOCK. EPR spectra confirm this assignment as the g1 = 2.93 resonance is missing in the spectrum 
of the H144A variant, Fig. 4B. The identity of the proposed Cys ligand seen only at low temperature in 
the EPR (above) was not established. The most likely candidate was considered to be Cys195 which 
points towards the heme pocket, but the EPR spectrum of the C195A variant (which corresponds to 
Cys170 in NPAS2 and has been suggested as a ligand (20)) was unchanged from that of the wild type 
protein, Fig. 4B. The uv-visible spectrum of the C195A variant is also very similar to the wild type, Fig. 
S4B, and thiol-modification of apo-hCLOCK with DTNB (to modify all Cys residues) followed by 
reconstitution with heme did not lead to a change in the uv-visible spectrum. Mutation of the adjacent 
Cys194 residue gave a similar heme-bound spectrum (lmax = 414 nm) and was presumed to bind heme 
normally in solution by virtue of the His144 ligand. Together, we interpret this information to mean that 
the Cys-ligated species is only present at low (cryogenic) temperatures.   
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We also expressed a PAS-B fragment of hCLOCK, Figs. 2 and S1, which was found to bind heme in 
the ferric form (lmax = 416 and 536 nm, Fig. S6) but with marginally weaker affinity (KD = 13.3 ± 0.97 
µM, Fig. S6) than the PAS-A form of hCLOCK. The PAS-B domain of NPAS2 is also reported as 
binding heme more weakly than the corresponding PAS-A domain (21) but the functional consequences, 
if any, of this difference are not known because the role of PAS-B is not yet established. The ferrous 
(lmax = 424, 532 and 559 nm, Fig. S6) and CO-bound forms (lmax = 421, 541 and 569 nm, Fig. S6) also 
form normally. Like the hCLOCK PAS-A domain, these spectra are indicative of a 6-coordinate heme 
binding interaction but this was not examined further in this work.  
 
Heme affects binding to the E-box. To assess the functional effect of heme on DNA binding, we 
expressed a construct of hCLOCK PAS-A containing an N-terminal HLH domain, Fig. 2 and Fig. S7A. 
The hCLOCK HLH-PAS-A construct was demonstrated to bind to E-box DNA (Fig. 5A); a plot of the 
relative band intensity versus [hCLOCK HLH/PAS-A] gave a KD = 6.3 μM, which is similar to that 
determined (KD = 9 μM) for a different construct of CLOCK containing only the HLH domain (22).  
Control experiments (Fig. 5B) with the corresponding HLH/PAS-A construct of NPAS2 (Fig. S7B and 
Fig. S8) similarly demonstrated binding of NPAS2 to E-box (KD = 11 μM, Fig. 5B). These HLH-PAS-
A proteins are presumed to bind to DNA as homodimers, as HLH domains are unable to form a specific 
interaction with E-box DNA in the monomeric form [13].  
 
Addition of heme inhibits DNA binding to the HLH domain of hCLOCK, as evidenced by the shift in 
the DNA band in EMSA assays, Fig. 5C; the same effect is observed for NPAS2, Fig. 5D. From the 
intensities of the DNA-protein and the the free DNA bands, an IC50 of 7.4 μM was derived for the 
inhibitory effect of heme on DNA binding to hCLOCK; this value is in the same range as the KD for 
heme binding to the PAS-A domain (KD = 3.7 μM, above). 
 
DISCUSSION 
The role of heme in circadian regulation. In addition to known roles as a prosthetic group in a multitude 
of heme proteins and enzymes, there is now emerging evidence that heme has a wider role to play in 
biology. A regulatory mechanism in cells that is linked to heme binding is, to our way of thinking, 
chemically logical and potentially versatile. Heme is redox active and, thus, responds to redox changes 
within the cell by modulating its oxidation state. Concentrations of heme in the cell are controlled by 
the balance of heme biosynthesis (to increase heme concentrations) and heme oxygenase activity (which 
degrades heme and produces CO as a by-product). Cell-signalling gases (O2, NO and CO) all bind to 
heme, which creates a possible mechanism of regulatory control. CO is itself produced by degradation 
of heme by the O2-dependent heme oxygenase enzyme, and NO is produced by the O2-dependent NO 
synthase enzyme. When one considers this in the context of circadian control, this means that the redox 
state of the cell, the oxidation state of heme, the balance between heme synthesis and degradation, and 
O2/NO/CO concentrations may all be inter-connected. This is summarised in outline form in Fig. 1. This 
interconnectivity could form the basis for a powerful heme-dependent circadian control mechanism that 
reflects metabolic activity. The fact that transcription of ALAS1, the first enzyme in the heme synthesis 
pathway, and other genes involved in heme catabolism (such as heme oxygenase) and heme transport 
(23-29) are also clock regulated is also significant as a means of connecting heme synthesis, heme 
degradation and CO formation to circadian events. Indeed, it has previously been shown that heme-
related genes in mouse are also implicated in the light resetting of the clock either as cause or effect 
(30). 
 
In the case of particular circadian proteins, several – including REV-ERB, PER2, NPAS2 – are shown 
to bind heme (12, 15, 20, 21, 31-40) and complex formation with partner proteins can be affected by 
heme or CO binding (34, 41, 42). And there are precedents for a circadian control mechanism that occurs 
through binding to PAS domain proteins, because of other regulatory PAS domain proteins that are 
known to bind heme (for example FixL in the histidine kinase family, the phosphodiesterases EcDOS 
and PDEA1 (43) and Burkholderia xenovorans RcoM (16)). 
 
Structure and heme ligation in hCLOCK. We have presented a structure for the PAS-A domain of 
hCLOCK. Heme is not bound to hCLOCK in this structure, although there is convincing evidence for 
non-covalent heme binding in the UV-visible and EPR spectra, as well as from the kinetic data. The 
absence of heme in our crystal structure does not imply a lack of specific heme binding - it may be that 
the particular conformation in which hCLOCK PAS-A crystallises is not compatible with heme binding 
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correctly in the cavity and thus heme is excluded during crystal formation. An absence of heme in the 
structure of a presumed heme binding protein has also been noted in the periplasmic heme transporter 
protein BhuT (44); this has been attributed to structural flexibility of the transporter complex.  
 
Heme binds relatively weakly to the PAS-A domain of hCLOCK, and weak heme binding is a feature 
of a number of regulatory heme binding proteins (20). The heme is proposed to reside at the mouth of a 
hydrophobic cavity comprising residues Phe 121, Leu 145, Leu 149, Phe 157 and Leu 198, Fig. S3. This 
is plausible in the sense that FixL also binds heme in a hydrophobic pocket (residues Val 188, Met 192, 
Tyr 203, and Ile 204) that helps to orient the heme and the His ligand (His200) in the correct location 
(8). Our comparison of the structures, Fig. S3, indicates that the heme binds at different locations in 
hCLOCK and FixL – both locations appear to be viable but the biological relevance of these differences 
is not yet known.  
 
From the available spectroscopic data for hCLOCK we assign the heme binding interaction in ferric 
hCLOCK as histidine-ligated at room temperature in solution. Data for the His144 variant strongly 
implicate this residue as a one of the heme ligands, and His144 is essential for heme binding. The 
hCLOCK protein appears to contain 6-coordinated (His/His) heme as evidenced by EPR, but appears 
able to adopt other distinct states with the axial ligand(s) being labile. The identity of the second histidine 
ligand is not known. There is evidence for a 5-coordinated ferric high-spin heme species from the EPR, 
again consistent with axial ligand lability (but His144 is presumed not to be labile, as it is essential for 
heme binding). These data are in agreement with those for NPAS2, which assign the equivalent residue 
(His119) as an axial ligand (20), Fig, S5. There is evidence from EPR only (empirical interpretation of 
the EPR g-values) for an additional Cys ligand to the heme in hCLOCK at 20 K. Cys ligation has been 
suggested in other heme regulatory proteins (16), but the spectroscopic evidence for it in the case of 
NPAS2 (where Cys170 has been proposed as a ligand, equivalent to Cys195 in hCLOCK, Fig. S5), and 
particularly in mPer2, is not totally conclusive. In the case of NPAS2, axial ligation might be affected 
by the presence of the N-terminal HLH domain (12, 20, 45). For hCLOCK, there are three Cys residues 
in the sequence and one of these (Cys250) is at >20 Å from His144. Cys195 points towards the pocket, 
but is still at >10 Å from the His144 ligand. The adjacent Cys194 residue is exposed and pointing away 
from the proposed heme pocket. A homology model of hCLOCK and NPAS2, Fig 6, indicates an 
overlay of the His144/His119 and Cys195/Cys170 residues. From the evidence available so far, our 
conclusions are that the axial ligand identities in hCLOCK – and, by analogy, in other related regulatory 
proteins – are not as straightforwardly defined as in other well-known heme proteins such as myoglobin 
(His/H2O), cytochrome b5 (His/His), cytochrome c peroxidase (His/H2O) or cytochrome P450 
(Cys/H2O) which have more rigidly coordinated heme ligands. Instead, we envisage these regulatory 
heme proteins as being much more fluid in their heme binding – and thus able to change their axial 
ligation in response to different stimuli, which could be binding to a protein partner, to DNA, to another 
heme ligand (such as CO) or to a change in oxidation state (16). This would require a degree of flexibility 
in the heme pocket which, in the case of the CLOCK protein, is consistent with the fact that PAS domains 
are known to be conformationally mobile (46). We have good evidence for conformational mobility of 
hCLOCK in our observations, namely the weak heme binding, the absence of heme in the crystal 
structure, and the required loss of the axial His ligand on CO binding to the ferrous form. This type of 
protein flexibility has been noted in other regulatory proteins (47) as well as in heme-based sensors (48), 
and could be a common feature of the way that these regulatory heme proteins operate. Further structural 
information will be important in resolving these questions.  
 
Effect of heme on DNA binding and functional implications. Our data demonstrate that heme inhibits 
binding of hCLOCK to DNA. This provides evidence for an influence of heme on the DNA binding 
ability of CLOCK in cells. How might this work and how might it affect signal transduction? We offer 
the following comments. If the proteins are conformationally mobile, for which there is evidence (as 
above), then it is plausible that heme binding to the PAS domain causes structural rearrangements that 
are transmitted and affect the interaction with the E-box. Based on the weak heme binding affinity, it is 
feasible that the heme binding event is itself reversible; reversible loss of heme has been noted in other 
systems recently (49) and could contribute to the regulatory control. The PAS domains that have been 
studied appear to initiate signalling from the central β-sheet region of the structure (50); the signal is 
then often propagated to the Cα helix of the PAS domain. His144, which binds to the heme in hCLOCK, 
is located on the Cα helix and conformational changes linked to heme binding in this proposed signalling 
region would therefore provide a convenient mechanism for signal transduction. Binding of signalling 
gases to the heme (such as CO) might also lead to structural rearrangements in the heme pocket, and 
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there is evidence for this in the related FixL sensor protein (51). How these signals are further propagated 
is not yet known. 
 
MATERIALS AND METHODS 
Detailed methods on the following subjects are available in SI Materials and Methods: cloning and 
mutagenesis, expression and purification, electronic spectroscopy, crystallisation, kinetic 
measurements, electrophoretic mobility shift assays.  
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FIGURE LEGENDS 
Figure 1. Simplified figure of mammalian regulatory clockworks (adapted from (52)). In the positive 
loop, NPAS2 (dark blue circle) and CLOCK (ditto) form heterodimers with BMAL1 (light blue) which 
bind to E-box to activate expression of PER (black) and CRY (orange). PER and CRY heterodimers 
then interact with the BMAL1 heterodimers to negatively regulate their own genes, thereby closing the 
loop (1). Other CLOCK-related genes are expressed, including the nuclear receptors REV-ERBa/b 
(green) and the retinoid receptor orphan receptor (ROR, pink). ALAS, which controls the synthesis (and 
hence the concentrations) of heme, is also clock-regulated. See introductory text for details. 
 
Figure 2. Domain structure in hCLOCK, showing the N-terminal HLH domains and the two PAS 
domains (PAS-A, PAS-B). The protein constructs used in this work are also shown. The vectors used 
for each construct design are shown in Fig. S1. 
 
Figure 3. A comparison of the structure of PAS-A domains. (A) hCLOCK as presented in this work 
(PDB code 6QPJ). His144 is indicated in red. This is similar to the equivalent PAS-A domain of mouse 
CLOCK protein in the CLOCK:BMAL1 complex (53). (B) The O2 sensor protein from Rhizobium (FixL 
(8)). (C) The heme-regulated phosphodiesterase from Escherichia coli (EcDOS, (9, 10)). In (A), and for 
mouse CLOCK, the protein crystallises in the apo-form. In (B) and (C), which both crystallise as the 
holo-protein, the heme molecule is indicated in red. The upper figures highlight the binding pocket 
created by the β-sheets; the lower structures (which are rotated by 90° about the indicated axis) show 
the similarity in overall arrangement of the domains. For direct comparison, an overlay of the hCLOCK 
and FixL structures is presented in Fig. S3.  
 
Figure 4. (A) UV-Visible absorption spectra of the ferric heme/CLOCK PAS-A complex. Inset shows 
DAbs at 415nm (obtained from difference spectra at various heme concentrations) as a function of heme 
concentration and fitted to a 1:1 binding event. (B) 9 GHz EPR spectra of ferric heme bound to hCLOCK 
PAS-A (top), the H144A variant of PAS-A (middle) and the C195A variant of PAS-A (bottom) in 50 
mM Tris/HCl buffer at pH 7.0. (C) Absorbance change at 412 nm for the dissociation of heme from 
hCLOCK PAS-A (3-4 µM) on mixing with apo-H64Y/V68F myoglobin (80 µM). Data are fitted to a 
double exponential process. (D) Spectrum of the ferrous (solid line), CO-bound (dotted line) and NO-
bound (dashed line) derivatives of heme-bound hCLOCK PAS-A.  (E) Observed rate constants for the 
association of CO with hCLOCK PAS-A, shown as a function of [CO] (top) and [hCLOCK PAS-A] 
(bottom). (F) Spectrum of the ferric heme/CLOCK PAS-A H144A complex (solid line) compared to 
free ferric heme (dotted line). This spectrum resembles that of the related His335 variant of NPAS2 
PAS-B (where H335 is assigned as one of the heme ligands) (21). 
 
Figure 5. Electrophoretic Mobility Shift Assays showing DNA binding to the HLH-PAS-A domains 
of hCLOCK (A, C) and NPAS2 (B, D) in the absence (A,B) and presence (C,D) of heme. 
 
Figure 6. The hCLOCK PAS-A crystal structure as presented in this work (in pale blue, PDB code 
6QPJ) superimposed on to a homology model of the PAS-A domain of NPAS-2 (in light grey). Cys195 
(equivalent to Cys171 in NPAS2, overlaid in grey) and Cys194 (equivalent to Tyr169 in NPAS2, not 
shown) in hCLOCK are shown in yellow; Cys250 in hCLOCK is also shown. His144 in hCLOCK is 
highlighted in red, overlaid with His119 in NPAS2 (in grey). The homology model was produced using 
SWISS-MODEL (Biozentrum, University of Basel) using the PAS-A domain of the mouse CLOCK 
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Supplementary Information Text 
Materials and Methods 
Cloning and mutagenesis. Constructs of human CLOCK (hCLOCK) were prepared from 
appropriate cDNA clones (Origene, Maryland, USA) by PCR and/or mutagenesis. Cloning into 
pLEICS expression vectors was performed by Dr. Xiaowen Yang at the PROTEX cloning and 
protein expression facility at the University of Leicester using a BD In-FusionTM kit. Cloning into 
pOPINRSE expression vector was done at the Oxford Protein Production Facility. The following 
constructs were prepared: hCLOCK PAS-A, hCLOCK HLH-PAS-A and hCLOCK PAS-B, Fig. S1. 
Schematic details of these constructs and expression vectors are given in Figures 1 and S1. For 
controls in gel shift experiments, related constructs of human NPAS2 were also prepared (Fig. S2).  
 
Expression and purification. All of the CLOCK constructs (PAS-A, HLH-PAS-A and PAS-B) 
produced soluble protein when overexpressed in E. coli and were purified in their apo-forms. The 
expression and purification protocols were thus the same for all of these constructs; yields ranged 
from 1-4 mg per liter of culture.  
E. coli Rosetta 2(DE3) cells were transformed with the relevant construct and grown in 2xYT media 
with 30 µg/mL kanamycin at 37°C to an OD600 of 0.6-0.8. Cells were induced by addition of IPTG 
(200 µM) and the cells incubated at 18 °C overnight. Cells were harvested by centrifugation at 
5,500 g for 20 minutes. Cell pellets were re-suspended in lysis buffer (50 mM potassium phosphate 
pH 8, 300 mM potassium chloride, 10 mM imidazole) containing a cOmplete, EDTA-free protease 
inhibitor cocktail (Roche), lysozyme (1 mg/ml), DNAse I (10 µg/ml) and magnesium sulphate (20 
mM). Cells were then lysed by sonication on ice at 8-10 microns amplitude for 30 seconds at a 
time, separated by 30 seconds intervals. Cell lysate was centrifuged at 38,700 g for 50 minutes 
and the supernatant was applied to a Ni-NTA column equilibrated with lysis buffer. The column was 
washed with 300 ml wash buffer (50 mM potassium chloride pH 8, 300 mM potassium chloride, 20 
mM imidazole) and the protein eluted using 0.1 M EDTA pH 8.0. Millipore centrifugation devices 
were used to exchange the protein into 50 mM potassium phosphate, 50 mM potassium chloride 
pH 8 buffer. Concentrated protein was incubated at 4 °C with TEV protease overnight to remove 
the 6xHis-tag. The protein was then passed through a Ni-NTA column using wash buffer and loaded 
onto a Superdex75 16/60 gel filtration column equilibrated with 50 mM Tris, 50 mM potassium 
chloride, pH 7.5. 
All proteins were expressed and purified in their apo-forms (i.e. without heme included). 
Reconstitution with heme was carried out by dissolving an arbitrary amount of hemin (typically 30-
40 mg) into 100 µl of 0.1 M NaOH. The solution was then diluted into 900 µl of 50 mM Tris, 50 mM 
potassium chloride, pH 7.5 buffer, and centrifuged at 20,000 g for 2 minutes. The supernatant was 
retained and centrifuged a second time at 20,000 g for 2 minutes. The insoluble pellet was 
discarded and 5 µl of soluble heme was further diluted into 1.0 ml of 50 mM Tris, 50 mM potassium 
chloride, pH 7.5 in order to determine its concentration ( 385 = 58.44 mM-1 cm-1). This heme solution 
was added to the relevant protein solutions. 
All purified proteins were assessed using SDS-PAGE, and by tryptic digestion followed by MALDI-
ToF mass spectrometry analysis. 
 
Preparation of protein derivatives. All absorbance spectra were measured using a Varian Cary 300 
Bio UV-visible spectrophotometer (25.0 °C). Ferrous heme spectra were generated by addition of 
sodium dithionite to ferric protein samples. The ferrous-oxy and ferrous-CO derivatives were 
generated by direct bubbling of O2 and CO gases, respectively, through dithionite-reduced 
samples. Binding constants for binding of heme to samples of apo-protein were determined 
according to (1). Modification of apo-CLOCK hCLOCK PAS-A (30 μM, in 50mM sodium phosphate 
pH 7.4) by reaction with Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid), DTNB) (3 mM final 
concentration) for 10 minutes at room temperature led to visible change in colour (to pale yellow) 
as the reaction proceeded. Excess DTNB and TNB were removed using a desalting column (GE 
Healthcare) which was equilibrated with 50 mM sodium phosphate pH 7.4 buffer. 
 
Crystallisation of hCLOCK PAS-A. The holo-protein was purified as described above, with a final 
Superdex 75 column to exchange the protein solution into 20 mM Tris-HCl, 150 mM NaCl pH 7.5. 





using a TTP Labtech Mosquito robot. Crystallisation of hCLOCK PAS-A in the apo- (heme free) 
form occurred from 2 µL of protein solution and 2 µL of reservoir solution (0.1 M MgSO4, 20% PEG 
3,350, 20 mM MES pH 6.5). Irregular, plate-like crystals of the apo-protein grew to their maximum 
size within a week at room temperature. Soaking of apo-crystals in a solution of hemin (over a 
range of concentrations) and co-crystallisation of holo-hCLOCK with hemin were attempted, but 
did not lead to formation of crystals of the holo-protein. Crystals of apo-protein were soaked in a 
cryoprotectant solution consisting of the reservoir solution plus 10% glycerol and then flash frozen 
in liquid nitrogen prior to data collection. Data collection was carried out at the University of 
Leicester home-source. The data sets were collected at 100 K using CuKa radiation (l = 1.5418 
Å) from a Rigaku MicroMax 007HF generator on a Rigaku Saturn 944+ detector. Data were indexed 
using iMOSFLM and then scaled and merged using AIMLESS as part of the CCP4 suite (2, 3). The 
protein crystallised as a homodimer with one monomer per asymmetric unit. The crystals belong to 
the I2 space group with unit cell dimensions of a = 46.0 Å b = 45.4 Å and c = 75.7 Å. Data collection 
and refinements statistics are shown in Table S1. The structure was determined by molecular 
replacement using the mouse CLOCK structure (PDB code: 4F3L) as the search model in Phaser 
(4) and refined with REFMAC (5) and COOT (6). Electron density of the polypeptide around H144 
is shown in Fig. S3D. 
 
EPR spectra. Protein samples (75-100 μM) were prepared in 50 mM Tris/HCl buffer at pH 7.0 and 
flash frozen into 4 mm quartz EPR tubes. Continuous-wave (CW) electron paramagnetic resonance 
(EPR) spectra at 9 GHz were recorded using a Bruker EMX spectrometer. The spectrometer was 
equipped with a super high sensitivity probe head and a liquid helium cryostat (Oxford Instruments). 
Typical spectra were recorded under non-saturating conditions at 20 K, 7 G modulation amplitude, 
100 kHz modulation frequency, 0.05 mW microwave power and 10 scans.  
 
Kinetic measurements. Heme dissociation kinetics were measured using a Varian Cary 300 Bio 
UV-visible spectrophotometer (25.0 °C) (7). Samples of holo-hCLOCK (1 μM, 50 mM potassium 
phosphate pH 7.0 containing 50 mM potassium chloride) were reacted with an excess 
concentration of apo-H64Y/V68F sperm whale myoglobin (80 μM). The H64Y/V68F variant has a 
high affinity for heme and transfer of heme from holo-protein to apo- H64Y/V68F is monitored at 
412 nm (7). Reported first order rate constants (kdiss, s-1) are an average of 2-4 determinations on 
different protein samples.  
Pseudo-first order rate constants (kCO, s-1) for binding of CO to hCLOCK (2 µM) were also 
determined by stopped flow. Solutions of CO at fixed concentrations were prepared by anaerobic 
dilution of a CO-saturated buffer (50 mM potassium phosphate containing 50 mM potassium 
chloride, pH 7.0, 25.0 oC).  
 
Electrophoretic Mobility Shift Assays. Samples containing double dilutions of protein (≤ 160µM), 
double stranded E-Box DNA (2 μM), 5% glycerol, and any additional ligands (e.g. heme) were 
prepared in 10 mM Tris/HCl containing 50 mM sodium chloride, pH 8.0. A 10 μM double stranded 
E-Box DNA stock solution was prepared by combining equal volumes of 10 μM 5’-
GAGGGGCGCCACGTGAGAGGCCT-3’ primer and 10 μM 5’-TAGGCCTCTCACGTGGC 
GCCCCT-3’ primer in 10 mM Tris containing 0.1 mM EDTA and 50 mM sodium chloride, pH 8.0, 
and stored at -20 °C. Samples were loaded on to a 0.7% agarose gel and separated by 
electrophoresis at 30 mA for 40 minutes. Gels were stained by soaking in 2.5 μg/ml ethidium 
bromide in 0.5 x TB buffer for 15 minutes, followed by destaining for 15 minutes in deionised water. 
UV light was used to visualise ethidium bromide bound to DNA and the intensity of the bands was 
quantified using Image J (NIH and LOCI, University of Wisconsin) software. The ratio of bound to 
unbound DNA was used (yielding units of relative band intensity) with the band intensity of the 






Fig. S1. Schematic figure showing the domains of the human CLOCK proteins studied in this 
work. The individual constructs along with details of the vector and purification tag are shown 


























Fig. S2. Gel filtration of hCLOCK PAS-A using a Superdex 75 16/60 gel filtration column. (A) A 
typical elution profile. (B) Calibration curve of hCLOCK PAS-A elution plotted with protein 
standards. Kav = (Ve−Vo)/(Vc−Vo), where Ve, Vo and Vc are the protein elution volume, the void 
volume of the column and the geometric column volume, respectively. The standards are 
abbreviated as follows C: Conalbumin (75 kDa); O: Ovalbumin (43 kDa); CA: Carbonic Anhydrase 
(29 kDa); R: Ribonuclease A (13.7 kDa); Apr: Aprotinin (6.5 kDa). hCLOCK PAS-A elutes at 60 mL 




























































































Fig. S3. (A) The structure of hCLOCK PAS-A (green) superimposed with the structure of FixL 
(yellow, PDB 1DRM). The RMSD of the two structures is 2.4 Å over 273 atoms. The heme of FixL 
is shown in red with its proximal histidine in blue and His144 of hCLOCK is shown in orange. This 
orientation is looking directly at the hydrophobic pocket which contains the heme group in FixL. (B) 
Space-filling representation of the same overlay, with the CLOCK structure shown in green overlaid 
onto a space filling image of FixL. The individual helices and sheets are labelled in green for 
hCLOCK, including the Ca helix (see Discussion). (C) The same cartoon representation of 
hCLOCK PAS-A as in (B) with the hydrophobic residues that form the mouth of the heme binding 
cavity shown as orange sticks and labelled accordingly. In this figure, the orientation is rotated 
slightly compared to (A) and (B) so that the position of His144 in the figure is not obscured by 
Phe121. (D) Local electron density of residues E143, H144 and L145 of hCLOCK (2Fo-Fc contoured 


































Fig. S4. (A) 9 GHz EPR spectrum at 4 K of ferric heme bound to hCLOCK PAS-A in 50 mM Tris/HCl 
buffer, pH 7.0. (B) UV-Visible absorbance spectra of ferric heme bound to the C195A mutant of 
hCLOCK PAS-A (lmax = 411, 533 nm). Absorbance values between 475-700 nm are magnified by 
a factor of five.   
100 150 200 250 300 350 400 450
 
Magnetic Fie ld (mT)






















































Fig. S6. Expression of hCLOCK PAS-B (construct shown in blue) gave a soluble protein (see 
methods). The UV-visible absorption spectrum shows that heme binds to hCLOCK PAS-B in the 
ferric (solid line), ferrous (dashed line) and ferrous-CO (dotted line) derivatives (50 mM phosphate 
and 50 mM potassium chloride buffer at pH 7.0). Inset shows DAbs at 415nm (obtained from 
difference spectra at various heme concentrations) as a function of heme concentration and fitted 







































Fig. S7. (A) SDS-PAGE of purified hCLOCK HLH/PAS-A (amino acids 24 to 265 with a C-terminal 
6 x His-tag, Fig. 2, 28.7 kDa) after expression in E. coli and elution from a Ni-NTA column. (B) SDS-
PAGE of purified hNPAS2 HLH/PAS-A (32 kDa). The protein expressed in E. coli (amino acids 6 
to 240 with an N-terminal 6 x His-tag and S-tag followed by a TEV cleavage site, Fig. S2). The 






















    













    





















Fig. S8. (A) Schematic figure showing the domains of human NPAS2 (top) along with the NPAS2 
constructs used in this work. NPAS2 constructs were overexpressed in E. Coli BL21(DE3) cells 
and purified in their apo-forms, following the procedure for expression and purification used for 
CLOCK PAS-A. A typical yield of 1 mg/L of soluble protein was obtained. (B) UV-visible spectrum 
of heme bound to ferric NPAS2 PAS-A (KD = 0.75 ± 0.04 µM). Absorbance values between 500-
700 nm have been magnified by a factor of five.  
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Table S1. Data collection and refinement statistics for hCLOCK PAS-A (PDB code 6QPJ). Values 
in parentheses are for high resolution shells 
 
Data Collection  
Resolution (Å) 25.0-2.30 (2.40-2.30) 
Total Measured Reflections 22826 
Unique reflections 6784 
Completeness (%) 98.4 (86.5) 
Redundancy 3.4 (2.6) 
I/s (I) 10.8 (2.8) 
Unit cell dimensions a = 46.0 Å b = 45.4 Å and c = 75.7 Å 
Space group I2 
Rmerge 0.07 (0.32) 
No. of monomers per asymmetric unit 1 
Refinement  
Resolution (Å) 25.0-2.30 
Rwork/Rfree 0.18/0.24 
r.m.s.d. bond (Å)/angle (˚) 0.008/1.28 
B-factor analysis (Å2)  
Protein 32.0 
Water 35.5 
Ramachandran analysis  
Most favoured (%) 96.12 
Allowed (%) 3.1 
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